Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)
Sebastian Dekkers(University of Nottingham), Michael J. Stocks(University of Nottingham), Chris de Graaf(Uppsala University), Meritxell Canals(University of Nottingham), Barrie Kellam(University of Nottingham), Stephen J. Hill(University of Nottingham), Birgit Caspar(Centre National de la Recherche Scientifique), Stephen J. Briddon(University of Nottingham), Laura E. Kilpatrick(University of Nottingham), Rob Leurs(Vrije Universiteit Amsterdam), Marta Arimont(University of Nottingham), Noémi Karsai(University of Nottingham), Dehan Çömez(University of Nottingham)
Cited by 4
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief
|Science Translational Medicine|2017|240
Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling
|Molecular Pharmacology|2003|187
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor
|Trends in Pharmacological Sciences|2020|157
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
|Pharmacological Reviews|2021|149